Biochemical and functional correlates of an increased membrane density of caveolae in hypertrophic rat urinary bladder

European Journal of Pharmacology

Volumn 649, Issue 1-3, 2010, Pages 362-368

  Shakirova, Yulia ^a   Swärd, Karl ^a   Uvelius, Bengt ^b   Ekman, Mari ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Caveolae; Caveolin 1; Cavin 1; Detrusor; Overactive bladder syndrome

Indexed keywords

BETA ACTIN; BRADYKININ; CARBACHOL; CAVEOLIN 1; CAVIN 1; CELL MEMBRANE PROTEIN; METHYL BETA CYCLODEXTRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CONTRACTION; BLADDER NECK STENOSIS; BLADDER OBSTRUCTION; CAVEOLA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; LIPID RAFT; MEMBRANE BIOLOGY; MORPHOMETRICS; MUSCLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SMOOTH MUSCLE CONTRACTILITY; SPRAGUE DAWLEY RAT;

ANIMALS; BRADYKININ; CARBACHOL; CAVEOLAE; CAVEOLIN 1; CELL MEMBRANE; FEMALE; HYPERTROPHY; MEMBRANE PROTEINS; MUSCLE CONTRACTION; MYOCYTES, SMOOTH MUSCLE; NEUROMUSCULAR AGENTS; PHOSPHOLIPASE C BETA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M3; URINARY BLADDER; URINARY BLADDER NECK OBSTRUCTION; URINARY BLADDER, OVERACTIVE;

EID: 78049282840     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.09.050     Document Type: Article

References (28)

1. Bastiani M., Liu L., Hill M.M., Jedrychowski M.P., Nixon S.J., Lo H.P., Abankwa D., Luetterforst R., Fernandez-Rojo M., Breen M.R., Gygi S.P., Vinten J., Walser P.J., North K.N., Hancock J.F., Pilch P.F., Parton R.G. MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes. J. Cell Biol. 2009, 185:1259-1273.
2. Chang S., Hypolite J.A., Mohanan S., Zderic S.A., Wein A.J., Chacko S. Alteration of the PKC-mediated signaling pathway for smooth muscle contraction in obstruction-induced hypertrophy of the urinary bladder. Lab. Invest. 2009, 89:823-832.
3. Cohen A.W., Hnasko R., Schubert W., Lisanti M.P. Role of caveolae and caveolins in health and disease. Physiol. Rev. 2004, 84:1341-1379.
4. de Weerd W.F., Leeb-Lundberg L.M. Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled Galpha subunits Galphaq and Galphai in caveolae in DDT1 MF-2 smooth muscle cells. J. Biol. Chem. 1997, 272:17858-17866.
5. Dreja K., Voldstedlund M., Vinten J., Tranum-Jensen J., Hellstrand P., Swärd K. Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1267-1272.
6. Gabella G., Uvelius B. Urinary bladder of rat: fine structure of normal and hypertrophic musculature. Cell Tissue Res. 1990, 262:67-79.
7. Goto Y., Yoshikane H., Honda M., Morioka S., Yamori Y., Moriyama K. Three-dimensional observation on sarcoplasmic reticulum and caveolae in myocardium of spontaneously hypertensive rats. J. Submicrosc. Cytol. Pathol. 1990, 22:535-542.
8. Hansen C.G., Bright N.A., Howard G., Nichols B.J. SDPR induces membrane curvature and functions in the formation of caveolae. Nat. Cell Biol. 2009, 11:807-814.
9. Hill M.M., Bastiani M., Luetterforst R., Kirkham M., Kirkham A., Nixon S.J., Walser P., Abankwa D., Oorschot V.M., Martin S., Hancock J.F., Parton R.G. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 2008, 132:113-124.
10. Kikuchi T., Oka N., Koga A., Miyazaki H., Ohmura H., Imaizumi T. Behavior of caveolae and caveolin-3 during the development of myocyte hypertrophy. J. Cardiovasc. Pharmacol. 2005, 45:204-210.
11. Kilsdonk E.P., Yancey P.G., Stoudt G.W., Bangerter F.W., Johnson W.J., Phillips M.C., Rothblat G.H. Cellular cholesterol efflux mediated by cyclodextrins. J. Biol. Chem. 1995, 270:17250-17256.
12. Lai H.H., Boone T.B., Yang G., Smith C.P., Kiss S., Thompson T.C., Somogyi G.T. Loss of caveolin-1 expression is associated with disruption of muscarinic cholinergic activities in the urinary bladder. Neurochem. Int. 2004, 45:1185-1193.
13. Lai H.H., Boone T.B., Thompson T.C., Smith C.P., Somogyi G.T. Using caveolin-1 knockout mouse to study impaired detrusor contractility and disrupted muscarinic activity in the aging bladder. Urology 2007, 69:407-411.
14. Lu Y.M., Han F., Shioda N., Moriguchi S., Shirasaki Y., Qin Z.H., Fukunaga K. Phenylephrine-induced cardiomyocyte injury is triggered by superoxide generation through uncoupled endothelial nitric-oxide synthase and ameliorated by 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxyindazole (DY-9836), a novel calmodulin antagonist. Mol. Pharmacol. 2009, 75:101-112.
15. Malmgren A., Sjögren C., Uvelius B., Mattiasson A., Andersson K.E., Andersson P.O. Cystometrical evaluation of bladder instability in rats with infravesical outflow obstruction. J. Urol. 1987, 137:1291-1294.
16. Mattiasson A., Uvelius B. Changes in contractile properties in hypertrophic rat urinary bladder. J. Urol. 1982, 128:1340-1342.
17. Patel H.H., Zhang S., Murray F., Suda R.Y., Head B.P., Yokoyama U., Swaney J.S., Niesman I.R., Schermuly R.T., Pullamsetti S.S., Thistlethwaite P.A., Miyanohara A., Farquhar M.G., Yuan J.X., Insel P.A. Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension. FASEB J. 2007, 21:2970-2979.
18. Polyák E., Boopathi E., Mohanan S., Deng M., Zderic S.A., Wein A.J., Chacko S. Alterations in caveolin expression and ultrastructure after bladder smooth muscle hypertrophy. J. Urol. 2009, 182:2497-24503.
19. Rothberg K.G., Heuser J.E., Donzell W.C., Ying Y.S., Glenney J.R., Anderson R.G. Caveolin, a protein component of caveolae membrane coats. Cell 1992, 68:673-682.
20. Saito M., Wein A.J., Levin R.M. Effect of partial outlet obstruction on contractility: comparison between severe and mild obstruction. Neurourol. Urodyn. 1993, 12:573-583.
21. Scott R.S., Uvelius B., Arner A. Changes in intracellular calcium concentration and P2X1 receptor expression in hypertrophic rat urinary bladder smooth muscle. Neurourol. Urodyn. 2004, 23:361-366.
22. Shakirova Y., Bonnevier J., Albinsson S., Adner M., Rippe B., Broman J., Arner A., Swärd K. Increased Rho activation and PKC-mediated smooth muscle contractility in the absence of caveolin-1. Am. J. Physiol. Cell Physiol. 2006, 291:1326-1335.
23. Shakirova Y., Mori M., Ekman M., Erjefält J., Uvelius B., Swärd K. Human urinary bladder smooth muscle in dependent on membrane cholesterol for cholinergic activation. Eur. J. Pharmacol. 2010, 634:142-148.
24. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1:31-39.
25. Sjuve R., Boels P.J., Uvelius B., Arner A. Up-regulation of bradykinin response in rat and human bladder smooth muscle. J. Urol. 2000, 164:1757-1763.
26. Woodman S.E., Cheung M.W., Tarr M., North A.C., Schubert W., Lagaud G., Marks C.B., Russell R.G., Hassan G.S., Factor S.M., Christ G.J., Lisanti M.P. Urogenital alterations in aged male caveolin-1 knockout mice. J. Urol. 2004, 17:1950-1957.
27. Wuest M., Eichhorn B., Grimm M.O., Wirth M.P., Ravens U., Kaumann A.J. Catecholamines relax detrusor through beta 2-adrenoceptors in mouse and beta 3-adrenoceptors in man. J. Pharmacol. Exp. Ther. 2009, 328:213-222.
28. Zeidan A., Javadov S., Chakrabarti S., Karmazyn M. Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ROCK-dependent p38 MAPK translocation to nuclei. Cardiovasc. Res. 2008, 77:64-72.